ctDNA for Minimal Disease Research by Hybridization Capture in Resected Cancer Samples
Offered By: Integrated DNA Technologies (IDT) via YouTube
Course Description
Overview
Explore how hybridization capture solutions are revolutionizing circulating tumor DNA (ctDNA) research for minimal residual disease (MRD) in this 17-minute webinar by Integrated DNA Technologies (IDT). Gain valuable insights into the significance of MRD research, its advantages over traditional methods, and its role in discovering new biomarkers. Understand how IDT's technology is helping researchers overcome challenges in ctDNA analysis for resected cancer samples. Discover the potential for new collaborations and breakthroughs in oncology research as these innovative studies are brought to the forefront. For more information, visit https://idtb.io/bmru7r.
Syllabus
ctDNA for minimal disease research by hybridization capture in resected cancer samples
Taught by
Integrated DNA Technologies (IDT)
Related Courses
El abordaje multidisciplinar de las demenciasUniversidad de Cantabria via MirÃadax Demystifying Targeted Cancer Treatments
Cancer Research UK via FutureLearn Diagnosis and prognosis biomarkers in global health
Institut Pasteur via France Université Numerique Extracellular Vesicles in Health and Disease
University of California, Irvine via Coursera Procalcitonin: PCT as a Biomarker for Antimicrobial Stewardship
The British Society for Antimicrobial Chemotherapy via FutureLearn